These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37749450)
1. TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma. Kim MS; Lee WS; Jin W Cell Mol Life Sci; 2023 Sep; 80(10):303. PubMed ID: 37749450 [TBL] [Abstract][Full Text] [Related]
2. TrkC-mediated inhibition of DJ-1 degradation is essential for direct regulation of pathogenesis of hepatocellular carcinoma. Kim MS; Lee WS; Park Y; Jin W Cell Death Dis; 2022 Oct; 13(10):850. PubMed ID: 36202793 [TBL] [Abstract][Full Text] [Related]
3. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
4. The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma. Fung SW; Cheung PF; Yip CW; Ng LW; Cheung TT; Chong CC; Lee C; Lai PB; Chan AW; Tsao GS; Wong CH; Chan SL; Lo KW; Cheung ST Cancer Lett; 2019 Aug; 457():98-109. PubMed ID: 31100412 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma. Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232 [TBL] [Abstract][Full Text] [Related]
6. ZnAs@SiO Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768 [No Abstract] [Full Text] [Related]
7. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway. Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517 [TBL] [Abstract][Full Text] [Related]
8. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1. Guo XL; Wang HB; Yong JK; Zhong J; Li QH Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839 [TBL] [Abstract][Full Text] [Related]
9. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance. Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303 [TBL] [Abstract][Full Text] [Related]
10. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
11. DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular Carcinoma. Chen X; Yang G; Guo X; Zhang J; Sun W; Liu D; Wang H; Liu S Oxid Med Cell Longev; 2022; 2022():2543220. PubMed ID: 35770048 [TBL] [Abstract][Full Text] [Related]
12. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition. Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927 [TBL] [Abstract][Full Text] [Related]
13. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway. Huang WC; Tung SL; Chen YL; Chen PM; Chu PY BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298 [TBL] [Abstract][Full Text] [Related]
14. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits. Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422 [TBL] [Abstract][Full Text] [Related]
15. Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma. Xiang X; Deng L; Xiong R; Xiao D; Chen Z; Yang F; Liu K; Feng G Cell Cycle; 2018; 17(11):1310-1318. PubMed ID: 30045663 [TBL] [Abstract][Full Text] [Related]
16. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442 [TBL] [Abstract][Full Text] [Related]
17. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma. Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025 [TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932 [TBL] [Abstract][Full Text] [Related]
20. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma. Liu S; Yang Z; Wei H; Shen W; Liu J; Yin Q; Li X; Yi J Hepatogastroenterology; 2010; 57(102-103):1247-56. PubMed ID: 21410067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]